Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Efficacy of Daratumumab Containing Regimens Post Lenalidomide Maintenance in Transplant Eligible Patients: Real-World Experience from the Canadian Myeloma Research Group Database

Hira S Mian, MD, Christine Eisfeld, Christopher P. Venner, MD, Victor Jimenez-Zepeda, MD, Cyrus Khandanpour, MD, Arleigh McCurdy, MD BSc, Michael Sebag, MD PhD FRCPC, Kevin W Song, MD FRCPC, Richard Leblanc, MD FRCPC, Esther Masih-Khan, PhD, Eshetu G Atenafu, MSc, P.Stat, Darrell J White, MD, Julie Stakiw, MD, Anthony Reiman, MD, Martha L Louzada, MDMSc, Muhammad Aslam, MD, Rami Kotb, MD, Engin Gul, BS, MBA, Donna E. Reece, MD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-133372

Published: 2020

Journal Articles

GFI1b As a Novel Oncosuppressor in AML

Aniththa Thivakaran, M.Sc., Lacramioara Botezatu, PhD, Judith Maria Hoenes, M.Sc., Yahya Saleh Al-Matary, MSc, Nadine Olberding, B.Sc, Judith Schütte, PhD, Renata Köster, Bertram Opalka, PhD, Ulrich Dührsen, MD, Cyrus Khandanpour, MD

Blood (2016) 128 (22): 2717.

https://doi.org/10.1182/blood.V128.22.2717.2717

Published: 2016

Journal Articles

the Role of MSCs in the Development of Acute Myeloid Leukemia

Yahya Saleh Al-Matary, MSc, Lacramioara Botezatu, PhD, Robert Fernando Lams, Aniththa Thivakaran, MSc, Renata Köster, Judith Schütte, PhD, Ulrich Dührsen, MD, Bertram Opalka, PhD, Cyrus Khandanpour, MD

Blood (2016) 128 (22): 2669.

https://doi.org/10.1182/blood.V128.22.2669.2669

Published: 2016

Journal Articles

Dose Dependent Role of Gfi1 in Human MDS and AML and Its Suitability As a Novel Target

Judith Maria Hönes, M.Sc., Lacramioara Botezatu, PhD, Lars C. Michel, Christian Thiede, MD, Bert van der Reijden, PhD, Michael Heuser, MD, Hideki Makishima, MD PhD, Jaroslaw P. Maciejewski, MD PhD, Tomas Radiovoyevitch, Gerhard Ehninger, MD, Ulrich Dührsen, Tarik Moroy, PhD, Cyrus Khandanpour, MD

Blood (2014) 124 (21): 777.

https://doi.org/10.1182/blood.V124.21.777.777

Published: 2014

Journal Articles

Function of Growth Factor Independence 1 (GFI1) in the Polarization AML -Associated Stroma

Lacramioara Botezatu, PhD, Yahya S. A. Al-Matary, Bertram Opalka, PhD, Jan Dürig, PD Dr., Thomas Schroeder, MD, Rainer Haas, MD, Ulrich Dührsen, Cyrus Khandanpour, MD

Blood (2014) 124 (21): 4366.

https://doi.org/10.1182/blood.V124.21.4366.4366

Published: 2014

Journal Articles

Gfi136N As a Novel Marker and Therapeutic Target of MDS and AML

Blood (2014) 124 (21): 3245.

https://doi.org/10.1182/blood.V124.21.3245.3245

Published: 2014

Journal Articles

Functional Inhibition of Mesenchymal Stem and Progenitor Cells (MSPC) Significantly Contributes to Hematopoietic Insufficiency with Acute Myeloid Leukemia (AML)

Stefanie Geyh, Manuel Rodríguez-Paredes, Cyrus Khandanpour, MD, Ron-Patrick Cadeddu, Paul Jäger, Christoph Zilkens, Ulrich Dührsen, MD, C. Matthias Wilk, Roland Fenk, MD, Norbert Gattermann, MD PhD, Ulrich Germing, Guido Kobbe, MD, Frank Lyko, PhD, Rainer Haas, MD, Thomas Schroeder, MD

Blood (2014) 124 (21): 3492.

https://doi.org/10.1182/blood.V124.21.3492.3492

Published: 2014

Journal Articles

A Single Nucleotide Polymorphism Of Growth Factor Independence 1 (GFI136N) is a Novel Prognostic Marker For The Progression Of Myelodysplastic Syndrome To Acute Myeloid Leukemia

Blood (2013) 122 (21): 2491.

https://doi.org/10.1182/blood.V122.21.2491.2491

Published: 2013

Journal Articles

The Growth Factor Independence 1 variant form GFI136N Predisposes to Acute Myeloid Leukemia by Inducing Epigenetic Changes in Oncogenes Such As Hoxa9

Cyrus Khandanpour, MD, Joseph Krongold, BSc,, Judith Schütte, Frederique Bouwman, Lothar Vassen, PhD, Marie-Claude Gaudreau, M.Sc., Riyan Chen, PhD., Sara E. Meyer, PhD, H. Leighton Grimes, PhD, Bert A. Van der Reijden, PhD, Joop H. Jansen, PhD, Bob Lowenberg, MD, PhD, Justine K Peeters, Patel Chandrashekhar, Ulrich Duehrsen, MD, Berthold Goettgens, PhD., Tarik Moroy, Ph.D.

Blood (2011) 118 (21): 223.

https://doi.org/10.1182/blood.V118.21.223.223

Published: 2011

Journal Articles

A Human Variant of Growth Factor Independence 1 (GFI136N) Predisposes to Myeloid Leukemia In Mice

Cyrus Khandanpour, MD, Lothar Vassen, PhD, Marie-Claude Gaudreau, MSc, Joseph Krongold, Bert van der Reijden, Ph.D., Joop Jansen, MD, Ulrich Duehrsen, MD, Tarik Moroy, Ph.D.

Blood (2010) 116 (21): 997.

https://doi.org/10.1182/blood.V116.21.997.997

Published: 2010

Journal Articles

Dosage-Sensitive Role of Growth Factor Independence 1 (Gfi1) In the Development of T-Cell Leukemia

Cyrus Khandanpour, MD, Tarik Moroy, Ph.D.

Blood (2010) 116 (21): 706.

https://doi.org/10.1182/blood.V116.21.706.706

Published: 2010

Journal Articles

Growth Factor Independence 1 b (Gfi1b) as a New Regulator of Hematopoietic Stem Cell Fate

Cyrus Khandanpour, MD, Lothar Vassen, PhD, Marie-Claude Gaudreau, MSc, Christian Kosan, Ph.D., Tarik Moroy, Ph.D.

Blood (2010) 116 (21): 837.

https://doi.org/10.1182/blood.V116.21.837.837

Published: 2010

Journal Articles

Growth Factor Independence 1 (Gfi1) Is Required for Initiation, Maintenance, Progression, and Transplantability of Lymphoma.

Cyrus Khandanpour, MD, Ehssan Sharif-Askari, PhD, Khashayar Afshar, Marie-Claude Gaudreau, Jinfang Zhu, Ph.D., William Paul, MD, Paul Jolicoeur, M.D., PhD, Ulrich Duhrsen, Tarik Moroy, PhD

Blood (2009) 114 (22): 447.

https://doi.org/10.1182/blood.V114.22.447.447

Published: 2009

Journal Articles

The Zinc Finger Protein Gfi1 Controls TLR4-Mediated Inflammatory Response by Directly Antagonizing NF-κB Transcription Factor

Ehssan Sharif-Askari, PhD, Hui Zeng, MD, PhD, Lothar Vassen, PhD, Christian Kosan, PhD, Cyrus Khandanpour, MD, Florian Heyd, PhD, Tarik Moroy, PhD

Blood (2008) 112 (11): 469.

https://doi.org/10.1182/blood.V112.11.469.469

Published: 2008

Journal Articles

Growth Factor Independence 1 (Gfi1) Is An Essential Factor for the Development of Lymphoma

Cyrus Khandanpour, MD, Ehssan Sharif- Askari, PhD, Paul Jolicoeur, MD, PhD, Ulrich Duehrsen, MD, Tarik Moroy, PhD

Blood (2008) 112 (11): 297.

https://doi.org/10.1182/blood.V112.11.297.297

Published: 2008

NARROW

Efficacy of Daratumumab Containing Regimens Post Lenalidomide Maintenance in Transplant Eligible Patients: Real-World Experience from the Canadian Myeloma Research Group Database

GFI1b As a Novel Oncosuppressor in AML

the Role of MSCs in the Development of Acute Myeloid Leukemia

Dose Dependent Role of Gfi1 in Human MDS and AML and Its Suitability As a Novel Target

Function of Growth Factor Independence 1 (GFI1) in the Polarization AML -Associated Stroma

Gfi136N As a Novel Marker and Therapeutic Target of MDS and AML

Functional Inhibition of Mesenchymal Stem and Progenitor Cells (MSPC) Significantly Contributes to Hematopoietic Insufficiency with Acute Myeloid Leukemia (AML)

A Single Nucleotide Polymorphism Of Growth Factor Independence 1 (GFI136N) is a Novel Prognostic Marker For The Progression Of Myelodysplastic Syndrome To Acute Myeloid Leukemia

The Growth Factor Independence 1 variant form GFI136N Predisposes to Acute Myeloid Leukemia by Inducing Epigenetic Changes in Oncogenes Such As Hoxa9

A Human Variant of Growth Factor Independence 1 (GFI136N) Predisposes to Myeloid Leukemia In Mice

Dosage-Sensitive Role of Growth Factor Independence 1 (Gfi1) In the Development of T-Cell Leukemia

Growth Factor Independence 1 b (Gfi1b) as a New Regulator of Hematopoietic Stem Cell Fate

Growth Factor Independence 1 (Gfi1) Is Required for Initiation, Maintenance, Progression, and Transplantability of Lymphoma.

The Zinc Finger Protein Gfi1 Controls TLR4-Mediated Inflammatory Response by Directly Antagonizing NF-κB Transcription Factor

Growth Factor Independence 1 (Gfi1) Is An Essential Factor for the Development of Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only